OrthoPediatrics corp’s recently made public that its General Counsel and Secretary Gerritzen Daniel J unloaded Company’s shares for reported $0.13 million on Mar 18 ’25. In the deal valued at $24.86 per share,5,310 shares were sold. As a result of this transaction, Gerritzen Daniel J now holds 110,767 shares worth roughly $2.24 million.
Then, Bailey David R sold 6,620 shares, generating $164,573 in total proceeds. Upon selling the shares at $24.86, the President and CEO now owns 319,155 shares.
Before that, Hite Fred sold 6,443 shares. OrthoPediatrics corp shares valued at $160,173 were divested by the COO and CFO at a price of $24.86 per share. As a result of the transaction, Hite Fred now holds 207,989 shares, worth roughly $4.2 million.
Lake Street initiated its OrthoPediatrics corp [KIDS] rating to a Buy in a research note published on April 07, 2025; the price target was $37. A number of analysts have revised their coverage, including Truist’s analysts, who decreased its forecast for the stock in late January from “a Buy” to “a Hold”. Needham also remained covering KIDS and reiterated its “Buy” recommendation on June 14, 2021. Needham maintained its rating on April 02, 2020. It rated KIDS as “a Buy”.
Price Performance Review of KIDS
On Tuesday, OrthoPediatrics corp [NASDAQ:KIDS] saw its stock fall -1.66% to $20.19. Over the last five days, the stock has lost -9.34%. OrthoPediatrics corp shares have fallen nearly -33.87% since the year began. Nevertheless, the stocks have fallen -12.90% over the past one year.
How much short interest is there in OrthoPediatrics corp?
A steep rise in short interest was recorded in OrthoPediatrics corp stocks on 2025-07-15, growing by 21482.0 shares to a total of 1.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 1.1 million shares. There was a rise of 1.92%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 08, 2020 when SunTrust began covering the stock and recommended ‘”a Buy”‘ rating along with a $54 price target.
